IBDEI1ZL ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33710,1,4,0)
 ;;=4^N32.0
 ;;^UTILITY(U,$J,358.3,33710,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,33711,0)
 ;;=N31.9^^131^1676^70
 ;;^UTILITY(U,$J,358.3,33711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33711,1,3,0)
 ;;=3^Neurogenic Bladder Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,33711,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,33711,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,33712,0)
 ;;=N31.1^^131^1676^71
 ;;^UTILITY(U,$J,358.3,33712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33712,1,3,0)
 ;;=3^Neuropathic Bladder,Reflex NEC
 ;;^UTILITY(U,$J,358.3,33712,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,33712,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,33713,0)
 ;;=N32.89^^131^1676^5
 ;;^UTILITY(U,$J,358.3,33713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33713,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,33713,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,33713,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,33714,0)
 ;;=N33.^^131^1676^4
 ;;^UTILITY(U,$J,358.3,33714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33714,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,33714,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,33714,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,33715,0)
 ;;=N34.2^^131^1676^99
 ;;^UTILITY(U,$J,358.3,33715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33715,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,33715,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,33715,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,33716,0)
 ;;=N34.1^^131^1676^100
 ;;^UTILITY(U,$J,358.3,33716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33716,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,33716,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,33716,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,33717,0)
 ;;=N39.0^^131^1676^104
 ;;^UTILITY(U,$J,358.3,33717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33717,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,33717,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,33717,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,33718,0)
 ;;=N31.0^^131^1676^72
 ;;^UTILITY(U,$J,358.3,33718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33718,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,33718,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,33718,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,33719,0)
 ;;=R31.9^^131^1676^54
 ;;^UTILITY(U,$J,358.3,33719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33719,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,33719,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,33719,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,33720,0)
 ;;=R31.0^^131^1676^52
 ;;^UTILITY(U,$J,358.3,33720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33720,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,33720,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,33720,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,33721,0)
 ;;=R31.2^^131^1676^53
 ;;^UTILITY(U,$J,358.3,33721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33721,1,3,0)
 ;;=3^Hematuria,Microscopic
 ;;^UTILITY(U,$J,358.3,33721,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,33721,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,33722,0)
 ;;=R31.1^^131^1676^51
 ;;^UTILITY(U,$J,358.3,33722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33722,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,33722,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,33722,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,33723,0)
 ;;=N40.0^^131^1676^30
 ;;^UTILITY(U,$J,358.3,33723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33723,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,33723,1,4,0)
 ;;=4^N40.0
